749
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Using observational analysis of multiple sclerosis relapse to design outcomes-based contracts for disease-modifying drugs: a feasibility assessment

, &
Pages 1146-1153 | Accepted 08 Jul 2013, Published online: 08 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Andrea Zimmer, Michael Coslovsky, Ivo Abraham & Bernhard F Décard. (2017) Adherence to fingolimod in multiple sclerosis: an investigator-initiated, prospective, observational, single-center cohort study. Patient Preference and Adherence 11, pages 1815-1830.
Read now
Luis Lizán, Marta Comellas, Silvia Paz, José Luis Poveda, Dennis M Meletiche & Carlos Polanco. (2014) Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature. Patient Preference and Adherence 8, pages 1653-1664.
Read now

Articles from other publishers (9)

Marion SchaufHarini ChinthapatlaSeema DimriEdward LiDaniel M. Hartung. (2023) Economic burden of multiple sclerosis in the United States: A systematic literature review. Journal of Managed Care & Specialty Pharmacy 29:12, pages 1354-1368.
Crossref
Nuriel Moghavem, Gloria del Rosario Castañeda, Amy J Chatfield & Lilyana Amezcua. (2023) The impact of medical insurance on health care access and quality for people with multiple sclerosis in the United States: A scoping review. Multiple Sclerosis Journal.
Crossref
G. T. Chidavaenzi, S. S. Grobbelaar & F. Salie. (2022) A Scoping Review Investigating the Use of Outcome-based Models to Improve Healthcare Outcomes and Reduce Healthcare Spending. A Scoping Review Investigating the Use of Outcome-based Models to Improve Healthcare Outcomes and Reduce Healthcare Spending.
Lucía Romero-Pinel, Laura Bau, Elisabet Matas, Isabel León, Roser Juvany, Ramon Jódar, Antonio Martínez-Yélamos & Sergio Martínez-Yélamos. (2022) Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator. PLOS ONE 17:4, pages e0267504.
Crossref
Joshua C. Toliver, Jamie C. Barner, Kenneth A. Lawson & Karen L. Rascati. (2021) Use of a claims-based algorithm to estimate disease severity in the multiple sclerosis Medicare population. Multiple Sclerosis and Related Disorders 49, pages 102741.
Crossref
Sissel Michelsen, Salma Nachi, Walter Van Dyck, Steven Simoens & Isabelle Huys. (2020) Barriers and Opportunities for Implementation of Outcome-Based Spread Payments for High-Cost, One-Shot Curative Therapies. Frontiers in Pharmacology 11.
Crossref
Jacqueline Nicholas, Huanxue Zhou & Chinmay Deshpande. (2020) Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis. Advances in Therapy.
Crossref
Maria K. HoutchensNatalie C. EdwardsAmy L. Phillips. (2018) Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS. Neurology 91:17.
Crossref
Brittany Gerber, Tara Cowling, Guanmin Chen, Michael Yeung, Pierre Duquette & Paola Haddad. (2017) The impact of treatment adherence on clinical and economic outcomes in multiple sclerosis: Real world evidence from Alberta, Canada. Multiple Sclerosis and Related Disorders 18, pages 218-224.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.